Checkpoint blockade in atypical meningiomas

Neuro-Oncology: The Podcast

English - August 20, 2021 12:07 - 39 minutes - 36.3 MB - ★★★★★ - 9 ratings
Medicine Health & Fitness Science Life Sciences brain oncology tumors glioblastoma glioma lymphoma neurology neurooncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Molecular signatures of glioma causation

Next Episode: 18F FET PET in childhood CNS tumors

Description: Dr. Nicholas Butowski interviews Dr. David Reardon about his recent manuscript "Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results", published online in Neuro-Oncology in May 2021.